Impact of anti-CD20 monoclonal antibodies on serologic response to

Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients - ScienceDirect

Anti-CD20 antibodies and bendamustine attenuate humoral immunity to COVID-19 vaccination in patients with B-cell non-Hodgkin lymphoma

Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis

Production of anti-spike antibodies in response to COVID vaccine in lymphoma patients

Anti-CD20 therapies for multiple sclerosis: current status and future perspectives

The future of anti-CD20 monoclonal antibodies: are we making progress? - ScienceDirect

Anti-CD20 therapies for multiple sclerosis: current status and future perspectives

Frontiers Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?

Anti-CD20 monoclonal antibodies in Systemic Lupus Erythematosus - ScienceDirect

Monoclonal Antibodies: A Tool in Clinical Research - Waliza Ansar, Shyamasree Ghosh, 2013